Edward J. Sitar

Edward J. Sitar (finance chief) discloses dealings in 3 companies, chiefly Vyant Bio, Inc., 9 Meters Biopharma, Inc. and Timber Pharmaceuticals, Inc. Between 21 May 2014 and 15 April 2023, the trades on record add up to 14 filings.

Both buying and selling appear: 8 purchases worth €114k, against 1 sale worth €4,847. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 share grants.

Half of the purchases are above €7,799 and half below. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 18 April 2023 with a share grant in Timber Pharmaceuticals, Inc. The last purchase on record was published on 24 November 2021, which is 1,795 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.